Unlicensed and Specials Medicines

The procurement process initiated by the Regional Business Services Organisation Procurement and Logistics Service relates to the supply of "Unlicensed and Specials Medicines" for Health and Social Care Trusts in Northern Ireland. This process is currently in the planning stage, with a significant Preliminary Market Engagement (PME) scheduled until the 27th of June 2025. The process involves gathering insights through a questionnaire and one-on-one Microsoft Teams meetings with potential suppliers on the 30th of June 2025.

The engagement aims to inform the development of a multi-supplier framework to be established potentially by May 2026. This buying organisation, located in Belfast, operates under Northern Irish devolved regulations and focuses on both pharmaceutical products and pharmacy services within the services industry category. This tender offers substantial growth opportunities for businesses specialising in pharmaceutical manufacturing or distribution, particularly those dealing with unlicensed or special medications.

Suppliers capable of providing aseptically prepared medicines, imported specials, non-aseptic specials, and over-labelled medicines could significantly benefit from this opportunity. Engaging in the PME offers a unique chance to influence the tender specifications and adapt to any potential procurement barriers. Businesses with a strong presence in Northern Ireland or the capacity to meet regional health trust demands will find this tender particularly advantageous.